Mesoporous silica nanoparticles in biomedical applications

Cited 1602 time in webofscience Cited 0 time in scopus
  • Hit : 487
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorLi, Zongxiko
dc.contributor.authorBarnes, Jonathan C.ko
dc.contributor.authorBosoy, Aleksandrko
dc.contributor.authorStoddart, J. Fraserko
dc.contributor.authorZink, Jeffrey I.ko
dc.date.accessioned2013-03-12T06:59:33Z-
dc.date.available2013-03-12T06:59:33Z-
dc.date.created2012-09-27-
dc.date.created2012-09-27-
dc.date.issued2012-
dc.identifier.citationCHEMICAL SOCIETY REVIEWS, v.41, no.7, pp.2590 - 2605-
dc.identifier.issn0306-0012-
dc.identifier.urihttp://hdl.handle.net/10203/101593-
dc.description.abstractThis tutorial review provides an outlook on nanomaterials that are currently being used for theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based materials. MSNPs with large surface area and pore volume can serve as efficient carriers for various therapeutic agents. The functionalization of MSNPs with molecular, supramolecular or polymer moieties, provides the material with great versatility while performing drug delivery tasks, which makes the delivery process highly controllable. This emerging area at the interface of chemistry and the life sciences offers a broad palette of opportunities for researchers with interests ranging from sol-gel science, the fabrication of nanomaterials, supramolecular chemistry, controllable drug delivery and targeted theranostics in biology and medicine.-
dc.languageEnglish-
dc.publisherROYAL SOC CHEMISTRY-
dc.subjectDRUG-DELIVERY RATE-
dc.subjectCANCER-CELLS-
dc.subjectORGANIC MODIFICATION-
dc.subjectCONTROLLED-RELEASE-
dc.subjectSURFACE-CHARGE-
dc.subjectMCM-41-
dc.subjectDOXORUBICIN-
dc.subjectNANOCARRIERS-
dc.subjectTUMOR-
dc.subjectSIZE-
dc.titleMesoporous silica nanoparticles in biomedical applications-
dc.typeArticle-
dc.identifier.wosid000301354900006-
dc.identifier.scopusid2-s2.0-84863337588-
dc.type.rimsART-
dc.citation.volume41-
dc.citation.issue7-
dc.citation.beginningpage2590-
dc.citation.endingpage2605-
dc.citation.publicationnameCHEMICAL SOCIETY REVIEWS-
dc.identifier.doi10.1039/c1cs15246g-
dc.contributor.nonIdAuthorLi, Zongxi-
dc.contributor.nonIdAuthorBarnes, Jonathan C.-
dc.contributor.nonIdAuthorBosoy, Aleksandr-
dc.contributor.nonIdAuthorZink, Jeffrey I.-
dc.type.journalArticleReview-
dc.subject.keywordPlusDRUG-DELIVERY RATE-
dc.subject.keywordPlusCANCER-CELLS-
dc.subject.keywordPlusORGANIC MODIFICATION-
dc.subject.keywordPlusCONTROLLED-RELEASE-
dc.subject.keywordPlusSURFACE-CHARGE-
dc.subject.keywordPlusMCM-41-
dc.subject.keywordPlusDOXORUBICIN-
dc.subject.keywordPlusNANOCARRIERS-
dc.subject.keywordPlusTUMOR-
dc.subject.keywordPlusSIZE-
Appears in Collection
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 1602 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0